Neal MillerCMO at Causeway TherapeuticsSpeaker
Agenda Sessions
Presentation: Disease Modification in Human Tendon Disease: The Clinical Translation of TenoMiR®, a First-in-Class microRNA-29a Mimic
, 12:00View Session
